Gisela Riu-Viladoms

7PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyGene and molecular therapyPredictive and prognostic markersClinical pharmacy and pharmacy practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 11, 2025
Evaluation of chemotherapy-induced nausea and vomiting in low, moderate, and highly emetogenic schemes between sexes.

Marta Albanell-Fernández, Ma Carmen Rodríguez Mues, Carolina Figueras

|May 25, 2024
Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation.

Daniel N Marco, Mònica Molina, Ana-María Guio

|Dec 23, 2023
At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program.

Sonia Ruiz-Boy, Alexandra Pedraza, Marta Prat

|Aug 11, 2023
Assessment of the change of antiemetic prophylaxis from double to triple combination in patients with high dose carboplatin chemotherapy.

Marta Albanell-Fernández, Ángela Pérez Sánchez, Inés Monge-Escartín

|Dec 23, 2022
Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide.

Daniel N Marco, María Queralt Salas, Gonzalo Gutiérrez-García

|Dec 11, 2022
Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53-Mutated Metastatic Colorectal Cancer.

Sara Lahoz, Adela Rodríguez, Laia Fernández

Pageof 2

Frequent Collaborators

3 joint publications

María-Queralt Salas

2 joint publications

Inés Monge-Escartín

2 joint publications

Marta Albanell-Fernández

2 joint publications

Laura Rosiñol